Mechanism of action of HTX-011: a novel, extended-release, dual-acting local anesthetic formulation for postoperative painThomas Ottoboni, Eugene R. Viscusi, Joseph F. Dasta et al.|Regional Anesthesia & Pain Medicine|2019Cited by 55
Hypersensitivity and Infusion-Site Adverse Events with Intravenous Fosaprepitant after Anthracycline-Containing Chemotherapy: A Retrospective StudyRalph V. Boccia, Thomas Ottoboni, Neil J. Clendeninn et al.|Future Oncology|2018Cited by 17
Response to the letter to the editor by Hafer and Johnson concerning ‘Mechanism of action of HTX-011: a novel, extended-release, dual-acting local anesthetic formulation for postoperative pain’Thomas Ottoboni, Eugene R. Viscusi, Jayne Pawasauskas et al.|Regional Anesthesia & Pain Medicine|2020Cited by 6
HTX-011, a Proprietary, Extended-Release Combination of Bupivacaine and Meloxicam, Reduces Acute Postoperative Pain Intensity and Opioid Consumption after Bunionectomy: Results From an Interim AnalysisEugene R. Viscusi, Barry Quart, Oscare DeLeon-Casasola et al.|Journal of the American College of Surgeons|2017Cited by 3